Obstetrics and Gynecology International / 2009 / Article / Tab 2

Clinical Study

Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use

Table 2

Blood product requirements before and after the administration of rFVIIa for major obstetric haemorrhage.

Pt no.FFP transfusedCryoprecipitatePlatelets transfusedRed cells transfused
(units)transfused (units)(pools)(units)
PrePostPrePostPrePostPrePost

1201000184
212010020213
3409020120
440552092
544010031111
640100021412
77318421122152
810630222010
900000000
10120201020180
11400000113
126151010252220
1387010221514
14100100102010
15453001066

Median409010146

0.1270.4130.7000.034

*Wilcoxon signed-rank test is shown.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.